Get the app
Petri Bono
Chief Medical Officer at Faron Pharmaceuticals and medical oncologist with extensive clinical research experience, discussing development of bexmarilimab targeting Clever-1 to reprogram macrophages in cancer treatment.
Best podcasts with Petri Bono
Ranked by the Snipd community
Dec 8, 2025
• 21min
Targeting Macrophages Instead of T Cells to Overcome Treatment-Resistant Cancers with Dr. Petri Bono Faron Pharmaceuticals
chevron_right
Dr. Petri Bono, Chief Medical Officer at Faron Pharmaceuticals and a seasoned oncologist, shares insights into an innovative cancer treatment using bexmarilimab. He explains how this groundbreaking immunotherapy targets the Clever-1 receptor on macrophages rather than traditional T cells, aiming to reprogram a tumor-supportive environment into one that actively fights cancer. Dr. Bono discusses the implications for higher-risk Myelodysplastic syndromes, trial results, and the potential to improve patient outcomes, including bridging patients to stem cell transplants.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
